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WHAT THIS PAPER ADDS
 The study provides further insight on the use of iliac branch device (IBD) for endovascular treatment of iliac/aorto-iliac aneurysms.
By reporting long-term results up to 5 years with 100 IBDs of current generation (data not yet largely available due to the relative
novelty of the technique), the study supports the durability in addition to the feasibility and safety of this approach to iliac
aneurysms.a r t i c l e i n f o
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Background: Iliac branch device (IBD) technique has been introduced as an appealing and effective
solution to avoid complications occurring during repair of aorto-iliac aneurysm with extensive iliac
involvement. Nevertheless, no large series with long-term follow-up of IBD are available. The aim of this
study was to analyse safety and long-term efficacy of IBD in a consecutive series of patients.
Methods: Between 2006 and 2011, 100 consecutive patients were enrolled in a prospective database on
IBD. Indications included unilateral or bilateral common iliac artery aneurysms combined or not with
abdominal aneurysms. Patients were routinely followed up with computed tomography. Data were re-
ported according to the KaplaneMeier method.
Results: There were 96 males, mean age 74.1 years. Preoperative median common iliac aneurysm
diameter was 40 mm (interquartile range (IQR): 35e44 mm). Sixty-seven patients had abdominal aortic
aneurysm >35 mm (IQR: 40e57 mm) associated with iliac aneurysm. Eleven patients presented hypo-
gastric aneurysm. Twelve patients underwent isolated iliac repair with IBD and 88 patients received
associated endovascular aortic repair. Periprocedural technical success rate was 95%, with no mortality.
Two patients experienced external iliac occlusion in the first month. At a median follow-up of 21 months
(range 1e60) aneurysm growth >3 mm was detected in four iliac (4%) arteries. Iliac endoleak (one type
III and two distal type I) developed in three patients and buttock claudication in four patients. Estimated
patency rate of internal iliac branch was 91.4% at 1 and 5 years. Freedom from any reintervention rate
was 90% at 1 year and 81.4% at 5 years. No late ruptures occurred.
Conclusions: Long-term results show that IBD use can ensure persistent iliac aneurysm exclusion at 5
years, with low risk of reintervention. This technique can be considered as a first endovascular option in
patients with extensive iliac aneurysm disease and favourable anatomy.
 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.l ESVS Vascular Meeting held
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ciety for Vascular Surgery. PublisheThe presence of common iliac artery aneurysm (CIA) preventing
the achievement of an effective seal and distal fixation is one of the
major anatomic challenges of conventional endovascular aneurysm
repair (EVAR). Extensive iliac aneurysm repair exposes a twofold
major safety issue: preservation of pelvic circulation to avoid
ischaemic complications and durable effective exclusion of the
aneurysm to prevent risk of rupture in the long term.1 Iliac branchd by Elsevier Ltd. All rights reserved.
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approach to deal with extensive aorto-iliac aneurysms allowing
effective preservation of antegrade flow of internal iliac artery (IIA).
In the last decade, a number of studies have assessed the feasibility
and safety of this novel endovascular technique showing that IBD
was effective in preventing complications such as buttock claudi-
cation, colon ischaemia and erectile dysfunction. Most of the
information available on IBD reports on perioperative or mid-term
outcomes2e6 often combining older- and new-generation
devices7e10 while today there are no data on the performance of
currently available IBD in the long term.
This study investigated the outcome of IBD up to 5 years after
repair.
Methods
Consecutive patientswho received IBD implantation from2006 to
2011 at two tertiary vascular centres (Unit of Vascular Surgery and
Endovascular, S. Maria della Misericordia Hospital, Perugia, Italy and
Unit of Vascular Surgery, S. Camillo-Forlanini Hospital, Rome, Italy)
were reviewed. Patients’ characteristics aswell aspreoperative, intra-
operativeand follow-upclinical and imagingdatawereobtained from
prospectively maintained computed databases since the first intro-
duction of the technique in January 2006. Patients treatedwith other
endovascular techniques, such as simple common iliac endograft,
bell-bottomor hypogastric coiling embolisation/occlusion during the
same period, were excluded from the present study. Pseudo-
aneurysms, symptomatic, and ruptured iliac aneurysms as well as
iliac aneurysms managed with open repair were also excluded.
Indication for treatment was the presence of unilateral or
bilateral CIA of 35 mm diameter or the occurrence of CIA of
25 mm diameter associated with abdominal aortic aneurysm
(AAA) 50 mm diameter. The selection for treatment with IBD was
based on anatomic characteristics of aorto-iliac vessels and severe
co-morbidities. Co-morbidities were defined according to the
Society of Vascular Surgeons/American Association for Vascular
Surgery (SVS/AAVS) reporting standards.11 Age of >80 years asso-
ciated with one or more severe co-morbidities (graded 2) were
usually indications for IBD repair if anatomical feasibility was
allowed. The IBD procedure was applied when the CIAs extended
distally to preclude appropriate distal landing zone with conven-
tional endovascular stent graft. When abdominal aortic diameter
was >35 mm or in the absence of suitable proximal CIA neck, IBD
release was associated with deployment of a bifurcated EVAR graft.
A patent lumen of the CIA of at least 18 mm in diameter, 40 mm in
length and a distal landing zone of at least 10 mm length on the
main IIA trunk was required for correct graft expansion. An
adequate length of external iliac artery (EIA) for a distal landing of
more than 15 mm and EIA diameter <12 mm were also required.
Exclusion criteria for IBD were severe IIA atherosclerosis, small CIA
diameter (<18 mm) at the level of bifurcation, severe kinking and
calcifications of EIA and wide angle of IIA off-sparing.
In case of bilateral CIA aneurysmal involvement, the side with
the most proximal healthy segment, with richer distal arterial bed,
without extensive calcification or tortuosity was chosen for IBD
placement. The other side was usually excluded with coil or plug
embolisation of IIA and overstenting into the EIA.
Contrast-enhanced computed tomographic (CT) aorto-iliac
imaging was obtained in all patients and used for preoperative
planning and then stored in a prospective computed data set.
IBD procedure
All patients received the Zenith straight version of the Zenith
iliac branch device (Cook, Bloomington, IN, USA), a second-generation IBD consisting in a bifurcated vessel graft including
a main iliac limb with an additional reinforced stump for the IIA
side branch. The Zenith IBD has a fixed proximal diameter of 12mm
and a distal diameter of 10, 12 or 16 mm, a common iliac segment
length of 45 or 61 mm and an EIA segment length of 41 or 58 mm.
The IBD was fitted within an indwelling catheter preloaded with
a 0.03500 guidewire and introduced through femoral access either
percutaneously or by small surgical cut down over a stiff guidewire
(Lunderquist, Cook Inc., Bloomington, IN, USA) and oriented under
fluoroscopic guidance. The delivery sheath was withdrawn,
exposing the tip of the preloaded catheter, and the preloaded
0.03500 guidewire was then snared from the contralateral side to
create a through-and-through access used to guide the introduc-
tion of a sheath that entered themain body of the device and exited
through the IIA side branch. Through this sheath, the IIA was
catheterised with a hydrophilic guidewire and a bridging covered
stent (Advanta, Atrium Medical, Hudson, NH, USA or Fluency, C.R.
Bard Peripheral Vascular Inc., Murray Hill, NJ, USA) was deployed to
fill the gap between the side branch of the IBD and the IIA, to ensure
adequate sealing and patency.
In the absence of suitable proximal CIA neck for landing or in the
presence of abdominal aortic diameter>35mm, the procedurewas
completed by deployment of the main bifurcated Zenith body from
the contralateral side and subsequent bridging the gap into the
proximal portion of the IBD with a Zenith iliac limb.
In the presence of IIA, landing of the internal branch was ach-
ieved on the IIA distal common trunk when available. Otherwise,
landing was reached on the largest and themost straight of the two
IIA distal division branches (anterior or posterior), while plug/coil
embolisation was reserved for the other smaller branch to avoid
distal type I endoleak.
Completion angiography was routinely performed to assess
accuracy of deployment, patency of IBD, aneurysm exclusion and
endoleak presence. The adequacy of external branch landing was
assessed with multiple views in double projection. If external iliac
angulation was caused or accentuated by the stent graft, an addi-
tional stent was deployed to straighten the external iliac artery at
the end of the procedure.
Follow-up protocol
A similar follow-up protocol was applied after repair in the two
centres. Abdominal ultrasoundwas performed in all patients before
discharge to evaluate patency and endoleak occurrence. Clinical
and ultrasound evaluations were repeated at 1 month and every 6
months. The imaging protocols included aorto-iliac CT imaging
within the first month after implantation and yearly thereafter, and
a plain X-ray at 6 months and yearly thereafter. A vascular dedi-
cated digital workstation (TeraRecon Aquarius Workstation, Terar-
econ, Foster City, CA, USA) was used for CT-scan imaging analysis
and three-dimensional (3D) reconstructions (Fig. 1). Arterial
diameters were measured as the shortest outside transverse
diameter of the artery on CT scans by the same observer. AAA and
iliac diameter changes were considered significant when exceeding
3 mm. Arterial length was measured with centreline of flow from
the CT scan.
Study end points and definitions
Primary outcomes were mortality, pelvic ischaemia (bowel,
spinal cord or nerve ischaemia, erectile dysfunction, buttock or
thigh claudication and buttock necrosis) and failure to exclude iliac
aneurysm (growth >3 mm in maximum diameter, endoleak or
rupture) up to 5 years after repair. Secondary outcomes were
technical success, defined as successful implantation of the IBD in
Table 1
Characteristics in 100 patients undergoing endovascular repair with Iliac branch
device (IBD).
N
Male gender 96
Mean age (yrs) 74.1  7.4
CIA diameter (median þ IQR) 40 (35e44)
Internal iliac aneurysm 11
Bilateral iliac aneurysm 9
AAA 67
AAA diameter (median þ IQR) 50 (40e57)
Smoking 24
Hypertension 84
Diabetes 10
Coronary artery disease 38
Renal insufficiencya 18
On dialysis 1
Previous aortic surgery 10
Endovascular AAA repair 3
Open AAA repair 7
COPDb 48
Co-morbidities were defined according to SVS standards as graded 1. AAA:
Abdominal Aortic Aneurysm; CIA: Common Iliac Aneurysm; IQR: Inter Quartile
Range.
a Renal insufficiency: elevated creatinine level, >1.5 mg/dl or on dialysis or with
kidney transplant.
b Chronic obstructive pulmonary disease: dyspnoea on exertion, chronic paren-
chymal X-ray changes, pulmonary function tests <65% of predicted.
Table 2
Perioperative results (30 days).
N
Mortality/Rupture 0
Mean procedure time (min) 135  17
Mean fluoro time (min) 39  21
Mean contrast (mL) 172  35
Technical failure 5
External iliac limb occlusion 2
Endoleak 2
Figure 1. 3-Dimensional reconstruction of Computed Tomography scan with
TeraRecon Aquarius Workstation in a patient with iliac side-branch repair for isolated
left iliac aneurysm.
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internal iliac tributaries, iliac patency (iliac branch or CIA patency;
EIA patency) and need for reintervention.
Statistical analysis
Measured values are reported as percentages and
means  standard deviations (SDs) or medians þ inter-quartile
ranges (IQRs). Change in aneurysm diameter over time was
assessed using analysis of variance (ANOVA) with Levene’s test for
equality of variance. Cox regression analysis with backward step-
wise method was used to analyse independent associations
between the risk of reintervention at 5 years and six covariates (age,
gender, iliac aneurysm >4 cm diameter, IIA aneurysm, associated
aortic repair and AAA >5.5 cm). KaplaneMeier survival estimates
were calculated to assess long-term outcomes (survival, reinter-
vention and patency); curves are displayed up to a value of stan-
dard error (SE) < 0.10.
A value of p < 0.05 was considered statistically significant for all
measurements. All analyses were performed using SPSS package,
13.0 version (SPSS Inc, Chicago, IL, USA).
Results
Between January 2006 and March 2011, 120 patients with CIA
were consecutively treated by endovascular route at two Italian
vascular centres. Twenty CIAs (16.6%) were excluded because
repaired by overstenting into external iliac artery with internal iliac
embolisation (n ¼ 18) or with Cardiatis SA (Isnes, Belgium) multi-
layer stent (n ¼ 2) leading to 100 IBD procedures representing the
present study population. Demographics, co-morbidities and
morphology characteristics of patients with CIA and IBD procedure
at baseline are shown in Table 1.
Most of the patients were males (n ¼ 96) and the mean age was
74.1 7.4 years (54e89 years). Baseline median diameter of treated
CIA was 40 mm (IQR, 35e44 mm). Eleven patients had an IIA
aneurysm (diameter >20 mm), 67 had AAA 35 mm associated
with iliac aneurysm and one had a thoraco-abdominal aneurysmrequiring branched aortic stent graft. Associated aortic aneurysms
showed diameter ranging from 35 to 68 mm (median 50 mm, IQR
40e57 mm). Twelve patients with suitable proximal iliac neck and
no AAA received isolated iliac repair with IBD and 88 underwent
IBD associated with endovascular aortic repair (EVAR). In nine
patients bilateral CIA was concurrently treated: in all cases IBD was
applied on one side and plug embolisation on the other side.
Perioperative results
Perioperative data are detailed in Table 2. Eighty-two proce-
dures were performed under local anaesthesia and in 35 percuta-
neous approach and closure devices were used.
Technical success was 95% due to five intra-operative IBD
occlusions. Four internal side branches occluded after long proce-
dures where difficulties were experienced in advancing the
contralateral sheath into the branch leading to thrombus shift into
the IIA during catheter and guidewiremanipulations inside the iliac
aneurysm. The remaining occlusion was due to impossibility to
correctly deploy the covered stent into the distal internal iliac
landing zone for excessive vessel tortuosity.
There were no perioperative deaths, myocardial infarctions,
strokes, conversions to open repair, mesenteric or spinal cord
infarcts or buttock necrosis. Major morbidity occurred in seven
patients, one had an episode of atrial fibrillation requiring medical
treatment, one patient had asymptomatic pulmonary embolism
detected at postoperative CT control, another had congestive heart
failure 7 days after discharge and another, with preoperative renal
failure, had a worsening of renal dysfunction requiring chronic
Figure 3. KaplaneMeier estimates of internal iliac side-branch patency rate.
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failure of closure device requiring surgical repair of the femoral
artery used for access.
During the first 30 postoperative days, two external iliac limb
occlusions occurred. Patency was restored in both by thrombec-
tomy and stenting.
Long-term follow-up
Median follow-up was 17 months (range 1e60; IQR 6e37). Only
one patient was lost after 2 years. All-cause survival at 5 years was
70.4% (Fig. 2). Thirteen patients died: only one death was aneurysm
related due to stent-graft infection detected 3 months after repair
and followed by sudden death. No autopsy was performed. Late
deaths were mainly related to cardiac disease (n ¼ 5 myocardial
infarction and n ¼ 4 congestive heart failure) or cancer (n ¼ 2).
Finally, one death occurred for liver failure. No aneurysm rupture
occurred. Four patients developed buttock claudication. Three
developed early after repair: two after intra-operative failure with
internal iliac side-branch occlusion and another in a case of bilat-
eral CIA successfully treated with IBD (patent) on one side and
contralateral IIA embolisation. The fourth buttock claudication
occurred after late occlusion of IIA branch 3 months from a proce-
dure of unilateral IBD repair for isolated CIA aneurysm.
AAA and CIA diameter
No AAA expanded in diameter, while iliac aneurysm growth
>3 mm was detected in four patients (4%). Seventy-two CIA
showed aneurysm shrinkage >3 mm during follow-up.
Compared to preoperative values, median iliac aneurysm
diameter significantly decreased during follow-up: from 40 (IQR,
35e44 mm) to 32 mm (IQR, 27e36), p < 0.0001 (by ANOVA).
Patency
Overall, seven occlusions of internal limb of IBD occurred. Five
were intra-operative as described above. In addition, one internal
iliac side-branch occlusion was recorded after 3 months and
another after 5 months. According to KaplaneMeier estimates, IBD
patency rate was 91.4% at 1 year and 91.4% at 5 years (Fig. 3).
During follow-up two external iliac limbs occluded. Both occlu-
sions occurred within 3 months of the procedure and were success-
fully restored, surgical cross-over femoro-femoral by-pass was
performed in one case and thrombectomy and stenting in the other.Figure 2. Five-year survival rate from all-cause death.Endoleak
Iliac endoleaks were recorded in three patients: two were distal
type I due to distal refilling from IIA branches occurring within the
first month and after 15 months and another was a type III due to
IIA stent disconnection from IIA side branch occurring during the
first month. All endoleaks were successfully corrected with
extension or interposition covered stent through brachial access.
Freedom from persisting iliac endoleak rate at 5 years was 100%.
Reinterventions
Nine reinterventions were performed during the follow-up
period for multiple reasons. Causes and types of reinterventions
are detailed in Table 3. Freedom from reintervention ratewas 90% at
1 year and 81.3% at 5 years (Fig. 4). Most reinterventions (7/9) were
performed for complications detected during the first 3 months
and related to intra-operative technical defects as detailed in
Table 3. Cox regression analysis found, among six potential
predictors of outcome, that only the presence of an IIA aneurysm
was a significant predictor of reintervention after 5 years from IBD
repair hazard ratio (HR) 5.9; 95% confidence interval (CI)
1.57e22.08, p ¼ 0.008.Table 3
Details of reinterventions.
Time
(months)
Indication Reintervention type
Patient 1 1 External iliac occlusion Thrombectomy þ stent
implantation
Patient 2 1 External iliac occlusion Thrombectomy þ stent
implantation
Patient 3 3 External iliac occlusion Thrombectomy þ stent
implantation
Patient 4 3 External iliac occlusion Femefem by-pass
Patient 5 1 Distal Type I, endoleak Covered stent implantation
Patient 6 15 Distal Type I, endoleak Covered stent implantation
Patient 7 1 Type III endoleak due to
Internal iliac side-branch
disconnection
Covered stent implantation
Patient 8 47 Iliac aneurysm growtha Aortobi-iliac stent graft
Patient 9 1 Femoral pseudoaneurysm Femoral patch
a This patient was originally treated with iliac branch device for isolated common
iliac aneurysm associated with ectatic but not aneurysmal aorta (diameter
<35mm). After 47months due to persisting growth of iliac aneurysm and due to the
presence of short proximal landing the repair was extended to apply a bifurcated
aortobi-iliac graft.
Figure 4. KaplaneMeier estimates of reintervention rate after iliac side-branch device
repair.
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To date, studies detailing IBD outcomes and patency over time
are lacking and long-term durability and efficacy are still unsolved
issues limiting the generalisation of the procedure. The present
analysis shows that IBD could be used as an independent procedure
or an EVAR adjunct for successful treatment of aortic aneurysms
with extensive iliac involvement ensuring both safety and dura-
bility of the repair up to 5 years.
Indeed, IBD was performed with no perioperative mortality, no
pelvic or colon ischaemia and 4% buttock claudication at 5 years.
The durability of iliac repair was confirmed by 91.4% IBD patency
and 81.3% freedom from reintervention rates at 5 years. Further-
more, >3 mm iliac aneurysm growth occurred only in four cases
suggesting the efficacy of the treatment. Nevertheless, our data are
based on a two-centre experience, limited numbers and no
controlled randomised design and could not be generalised in
many other settings.
The use of newer-generation IBDs as well as an improved
understanding of these devices may have played an important role
in achieving valuable side-branch patency rates reported to be over
80% in most of the recent series on IBD. Ferreira et al. published
secondary patency rate of 87.3% and primary patency rate of 85.4%
at 22 months over 47 IBDs in 37 patients.3 Pua et al. reported an
excellent 100% side-branch patency rate even though they analysed
a small group of 14 IBDs with a maximum of 35 months (mean 18.7
months) of follow-up.5 Donas et al. recently showed patency rate of
98.4% at a mean follow-up of 30.5 months in their group of 64 IBD
compared to 54 iliac aneurysms receiving open repair.6 Our iliac
patency rate of 91.4% compares favourably with other reported IBD
patency rates in literature also due to the longer time estimation.
Of relevance, data support that the use of IBD is effective in
preserving pelvic circulation and avoiding the risk of buttock clau-
dication occurring in about 30% of patients after endovascular repair
of CIA with embolisation/coverage of the IIA.12e14 On the contrary,
the risk of side-branch occlusion after IBD implantation is not
related to severe clinical consequences. A large recent review of 196
IBD from nine literature series showed that only half of the patients
with side-branchocclusion (12/24)maydevelop symptomsof pelvic
ischaemia after IBD occlusion.10 Accordingly, in our series, buttock
claudicationwas recorded only in three of the overall sevenpatients
with internal iliac side-branch occlusion (43%). No other more
serious pelvic ischaemia manifestations (mesenteric or spinal cord
infarcts, or buttocknecrosis)were recordedup to5years after repair.Whether bilateral IIA coverage can further increase the risk of
buttock claudication is a subject of debate.12,13 In the pooled analysis
of Rayt et al. including 634 patients who had undergone either
unilateral or bilateral IIA occlusions, buttock claudication occurred in
31% of unilateral embolisations (99 of 322) and in 35% of bilateral
embolisations (34 of 98; p¼ 0.46 Fisher’s exact test).13 The use of IBD
can decrease the need for bilateral IIA occlusion in the presence of
bilateral CIAdisease. In our experience, nine patientswere treated for
bilateral CIA and in all the cases one IIAwas preservedwith IBDwhile
the contralateral IIA was occluded with plug. Only one buttock clau-
dicationdeveloped (on thesideof occluded IIA) amongbilateral cases.
The major disadvantage of IBD is the technical feasibility related
to anatomical requirements. Our major reasons for technical failure
were related to severe vessel tortuosity or iliac anatomies not totally
fulfilling criteria for IBD application. Furthermore, four of the five
technical failures occurred during the first year of experience with
IBD (in each of the two centres) confirming an important role of
initial experience and learning curve effect (including morphology
selection) on IBD outcomes. Technical success is expected to
improve with better understanding of the device, increased device
familiarity and better patient selection in the future.
Today, there are no standardisedmorphologic criteria for IBDuse,
also because of the sparse and various experiences with small IBD
numbers. Preoperative planning with the use of 3D imaging recon-
structions to identifyappropriate iliac artery lengths anddiameters is
an essential tool to provide persisting success of the IBD procedure.
As with any endovascular procedure, IBD application presents
unavoidable anatomical feasibility limitations. These mainly rely on
EIA and IIAvessels suitable fordistal landing. Thepresenceof small or
tortuous EIA or the concurrence of large IIA are main negative
predictorsofoutcome. Inour series theonly independentpredictorof
the need for reintervention after IBD was the presence of IIA aneu-
rysm (HR 5.8, p¼ 0.008). Furthermore, four external limbs occluded,
all within the first 3 months after the procedure and related to the
presence of external anatomy not best suited for stent-graft landing.
Liberalisation of morphology indications may result in decreased
efficacy and durability and increased endoleak/failure rates. Donas
et al. noted high endoleak rate (12.5%) in 65 IBDs, even though all of
these were successfully managed with reintervention.6 The authors
usedminimal anatomical characteristics for IBD application of CIA of
>30 mm in diameter and >50 mm in length and iliac bifurcation
diameter>15mm. Furthermore, challenging internal iliac anatomies
including aneurysms >11 mm, short and absent neck for distal
landing, were also included.6 In our study, three endoleaks over 100
IBD procedures were recorded. The rate was comparable and also
lower than those shown in other literature data reporting 0e8.5%
endoleak rates after IBD.2,5,8e10 Our endoleaks were easily treated
with successful reinterventions allowing a zero rate of persisting
endoleak at 5 years. Furthermore, 2/3 endoleaks occurred early,
during the first month after the procedure, as a consequence of an
inappropriate length of distal landing, suggesting that better
anatomical criteria selectioncouldhaveavoided thesecomplications.
Freedom reintervention rates (81.3% at 5 years) that we found
after IBD compared well with reintervention data reported in the
long term in other EVAR series without adjuncts. Unfortunately,
poor meaningful comparisons in reintervention rates for our data
can be drawn from an available series on IBD due to differences in
measurements and time of assessment. In the experience of Dias
et al. on 22 IBDs, crude reintervention rate was 18% at a mean
follow-up of 20 months.2 Karthikesalingam et al. noted that over
nine series on 196 patients with IBD, 12 reinterventions were re-
ported.10 As in conventional EVAR, long-life clinical and imaging
surveillance remains important after implantation of IBD.
The overall low endoleak and reintervention rates up to 5 years
after IBD may suggest the efficacy of the technique in aneurysm
G. Parlani et al. / European Journal of Vascular and Endovascular Surgery 43 (2012) 287e292292exclusion. This efficacymaybedue also to the small rate of aneurysm
growth after repair. In our series only for CIAs enlarged after IBD and
no aneurysm ruptured. However, this efficacy end point needs to be
corroborated byprospective andalso randomised controlled studies.
Major limitations of this study include the lack of a randomised
design with associated selection biases and the lack of a control
group to compare the clinical relevance of our results. Indications
for IBD were based on subjective criteria even though the series
was consecutively collected. Furthermore, the study was based on
a two-centre experience and data could not be generalised in other
outside settings.
Conclusions
The use of IBD for treatment of extensive iliac aneurysms can
allow durable aneurysm exclusion with low rates of iliac branch
occlusion and reintervention at 5 years. Risk of pelvic ischaemia is
low either during the procedure or in the long term. Positive
outcomes after IBD are strongly related to anatomical feasibility
and proper patient selection. IBD could be used as a primary choice
for endovascular treatment of iliac aneurysms with extensive
disease and favourable anatomy.
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